Pioneering a path
forward for patients
and families
Pioneering a path
forward for patients
and families
Sabrina, living with Bardet-Biedl syndrome,
and her mother Ann
Luna, patient living with Bardet-Biedl syndrome
At Rhythm Pharmaceuticals, we’re committed to transforming the lives of patients with rare neuroendocrine diseases.
Who we are
We are a community-focused company, dedicated to patients, their families, and healthcare providers.
Advancing science
We continue to advance care and medicines that address rare neuroendocrine diseases.
Inclusion and belonging
We believe that each person brings a unique contribution to furthering our mission. Therefore, we are investing in a work environment where our employees feel inspired and included.
Rhythm Pharmaceuticals is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and medicines that address the root cause.1
Our expertise and close collaboration with patients, caregivers, and healthcare professionals enable us to understand the complex challenges of rare melanocortin-4 receptor (MC4R) pathway diseases and identify where unmet needs lie.
We combine translational research and clinical development to deliver integrated medicine to tackle challenges in rare MC4R pathway diseases
Meet the Stewart family
Katherine and Elizabeth Stewart were both diagnosed with Bardet-Biedl syndrome as children. Learn about Katherine and Elizabeth’s journey to diagnosis and how they navigate the challenges of living with Bardet-Biedl syndrome (BBS).
Join Us
Our people are our greatest strength. We've built an inclusive, inspiring workplace where everyone can do their best work—and in our fast-growing, collaborative company, your contributions truly matter.
References
- 1.
Fonseca ACP, et al. J Diabetes Complications. 2017;31(10):1549–1561